GLUTASIM 7MG Tablet by Saffron Pharma contains Semaglutide 7mg, an oral GLP-1 receptor agonist prescribed as part of a comprehensive treatment plan for adults with type 2 diabetes. It is used alongside a healthy diet and regular physical activity to help improve blood glucose control.
Semaglutide works through several complementary effects, including increasing glucose-dependent insulin secretion, reducing inappropriate glucagon secretion, slowing gastric emptying, and influencing appetite. These effects can help improve blood sugar management and may also contribute to weight reduction in some patients.
GLUTASIM 7MG is an oral tablet and should be taken exactly according to the instructions provided by your healthcare professional.
GLUTASIM 7MG Tablet is an oral medicine containing:
Semaglutide belongs to the GLP-1 receptor agonist class of medicines. Oral semaglutide may be prescribed to help adults with type 2 diabetes achieve better blood glucose control when used together with appropriate diet and physical activity.
Semaglutide helps regulate blood glucose levels as part of a comprehensive type 2 diabetes treatment plan.
Semaglutide activates GLP-1 receptors that are involved in glucose regulation, insulin secretion and appetite control.
It enhances insulin secretion when blood glucose levels are elevated.
Semaglutide can reduce inappropriate glucagon secretion, helping regulate the amount of glucose released by the liver.
It can slow the movement of food from the stomach, which may influence glucose absorption and contribute to feelings of fullness.
Semaglutide may affect appetite and food intake, although the response varies between individuals.
GLUTASIM 7MG provides semaglutide in tablet form for patients prescribed oral semaglutide therapy.
Semaglutide is a long-acting GLP-1 receptor agonist that mimics the action of the naturally occurring hormone GLP-1.
It works through several mechanisms:
1. Stimulates insulin secretion when glucose is elevated
Semaglutide helps the pancreas release more insulin when blood glucose is high.
2. Reduces inappropriate glucagon secretion
Glucagon stimulates glucose release from the liver. Semaglutide helps reduce glucagon secretion when it is not needed.
3. Delays gastric emptying
Food may pass more slowly from the stomach, affecting the rate at which glucose enters the bloodstream.
4. Influences appetite and food intake
GLP-1 receptor activity can increase feelings of fullness and reduce food intake in some people.
Your healthcare provider may prescribe GLUTASIM as part of treatment for:
The appropriate indication depends on the product's approved labeling and your healthcare professional's assessment.
GLUTASIM should not be used as a replacement for a healthy diet, exercise, or other prescribed diabetes treatment unless your doctor specifically advises it.
GLUTASIM 7MG may be considered for adults with type 2 diabetes who:
Your doctor will assess your medical history, current medications, blood glucose levels and treatment goals before prescribing semaglutide.
| Active Ingredient | Strength | Function |
|---|---|---|
| Semaglutide | 7mg | GLP-1 receptor agonist that helps regulate blood glucose |
Oral semaglutide has specific administration requirements because food and other medicines can affect its absorption.
The 7mg strength is commonly used as a maintenance dose after an initial lower dose of oral semaglutide, when appropriate. Do not start, increase or decrease the dose without medical advice.
If you miss your daily dose, follow the missed-dose instructions provided with your prescribed product.
Do not take two doses together to compensate for a missed dose.
If you frequently miss doses, speak with your doctor or pharmacist for advice.
Like all medicines, GLUTASIM 7MG may cause side effects. Gastrointestinal effects are among the most commonly reported with semaglutide.
These effects may be more noticeable when treatment is started or the dose is increased.
Tell your healthcare provider before taking GLUTASIM if you:
Semaglutide products carry an important warning concerning thyroid C-cell tumors. Tell your healthcare provider if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tell your doctor or pharmacist about all medicines you use, particularly:
Because oral semaglutide has specific administration requirements and may delay gastric emptying, your healthcare provider may need to review the timing of other oral medicines.
If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using GLUTASIM 7MG.
Semaglutide is generally not used for weight-loss treatment during pregnancy. Treatment decisions during pregnancy should always be made by a qualified healthcare professional.
If you become pregnant while taking semaglutide, contact your healthcare provider.
GLUTASIM does not normally directly impair driving. However, low blood sugar can affect concentration and coordination, particularly when semaglutide is used with insulin or sulfonylureas.
If you experience dizziness, weakness, blurred vision or other symptoms of hypoglycemia, avoid driving and seek medical advice.
Provides Semaglutide 7mg, a GLP-1 receptor agonist used in type 2 diabetes management.
Provides semaglutide in a convenient oral dosage form.
The 7mg strength may be prescribed as part of an oral semaglutide dose-escalation regimen.
GLUTASIM 7MG Tablet is manufactured by Saffron Pharma.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ahmed R. – Lahore
"SuperCare Pharma made the ordering process easy, and my package arrived securely packed."
⭐⭐⭐⭐⭐ Bilal M. – Karachi
"Good online pharmacy service and the product was received in secure packaging."
⭐⭐⭐⭐⭐ Usman K. – Islamabad
"Easy ordering process and prompt delivery. The package was well packed."
| Product Information | Details |
|---|---|
| Brand | GLUTASIM |
| Manufacturer | Saffron Pharma |
| Generic | Semaglutide |
| Strength | 7mg |
| Dosage Form | Tablet |
| Pack Size | 10 Tablets |
| Medicine Type | Prescription Medicine |
| Drug Class | GLP-1 Receptor Agonist |
GLUTASIM 7MG contains semaglutide and may be prescribed as part of a treatment plan for adults with type 2 diabetes to help improve blood glucose control.
Each tablet contains Semaglutide 7mg.
Oral semaglutide is generally taken once daily on an empty stomach with a small amount of plain water. Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines.
The 7mg strength is commonly used as a maintenance dose after an initial lower dose of oral semaglutide. Do not start or change to 7mg without your doctor's instructions.
Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion and decreased appetite. Contact your doctor if symptoms are severe or persistent.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient delivery across Pakistan
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
GLUTASIM is a prescription medicine. Use it only according to the advice of a qualified healthcare professional.
Looking for GLUTASIM 7MG Tablet (Semaglutide) by Saffron Pharma? Order through SuperCare Pharma for a convenient online pharmacy experience and delivery across Pakistan.
Use semaglutide exactly as prescribed and do not change the dose without consulting your healthcare professional.
